Marie-Hélène Guertin has a PhD in epidemiology from Université Laval in Québec city. She coordinates the performance evaluation team of the Québec breast cancer screening program. Over the past 15 years, she has been working on projects concerning breast cancer screening, lung cancer screening and colorectal cancer screening.

Bart Homan is a PhD researcher working on improving the colorectal cancer screening and surveillance program within the ASCCA project at Amsterdam UMC. He has a BSc in International Business from the Amsterdam University of Applied Sciences and a MSc in Economic Policy from Utrecht University. In previous research, he focused on the effects of bundled payments on health outcomes and care expenditures in the Dutch maternity care sector. In his current research he will focus on cost effectiveness and overall effectiveness of the Dutch colorectal cancer screening program.

Alicia Dallisson is a Medical Science Honours student in the Bowel Health Service team at Flinders University. Alicia is interested in finding novel, simplified methods to increase screening participation and reduce the incidence of colorectal cancer.

Karen O. Binderup is a Ph.D.-student and medical student, studying the utility of DNA-methylation testing in gynaecological cancers. Her pre-graduate research focused on risk-stratification of older screen-positive women without a fully visible transformation zone at colposcopy, as this group of women poses a clinical diagnostic challenge. Her Ph.D.-research project aims to validate DNA-methylation testing in patient-collected urine and vaginal samples for endometrial cancer risk-stratification of women with postmenopausal bleeding.

Severien Van Keer graduated as biomedical scientist and is currently working as Assistant Professor at the University of Antwerp, Belgium. Her research focuses on translational cervical cancer research to demonstrate the acceptability and clinical accuracy of HPV testing in self-samples, including first-void urine, with host cell methylation marker triage.

Urologist specialising in Prostate Cancer based in Dublin. Trained in Ireland and completed the Urology Oncology fellowship in Memorial Sloan Kettering cancer centre in New York in 2010. Appointed to Colchester, Essex and later Mater and St Vincents hospitals in Dublin. Appointed Associate Professor in UCD. Established the Irish Prostate Cancer Outcome registry (IPCOR) in 2016 and leads on the ProstateCheck.ie prostate cancer screening pilot.

Jane Lange is a statistician and cancer modeler specializing in early detection research. Her research interests include estimating disease natural histories from surveillance data, medical decision making using microsimulation and analytic models, and developing tools to project the population impact of multi-cancer early detection tests.